Company: CRAC
Filing Date: 2025-09-04
Form Type: S-1/A
Source: 0001213900-25-084243
Chunk: 16

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-09-04
Form: S-1/A
Chunk 16
---
 shares for all of your Share Rights upon closing of a business combination. Unless we tell you otherwise, the information in this prospectus assumes that the underwriters will not exercise their over -allotment option and the forfeiture by our sponsor of 562,500 founder shares. Our Company General We are a blank check company incorporated on April 29, 2025 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. 2 Purpose Crown Reserve Acquisition Corp. I intends to identify and acquire a business within an industry or sector that complements the experience of our management team and can benefit from our operational expertise. We will have a generalist approach to industry sectors, but with particular emphasis on industries where we have core competencies and experiences, such as pharma, medical technology and medical equipment, and healthcare IT industries. However, we may pursue an initial business combination opportunity in any industry or sector (subject to certain limitations described in this prospectus). Our Leadership Our management team and board consist of seasoned industry executives that possess deep collective understanding of various industries, including the pharma, medical technology and medical equipment, and healthcare IT, as well as the evolution of these sectors and market opportunities. Management Team Prashant Patel(age: 51) serves as Chairman and Chief Executive Officer. Mr.Patel served as a director and president of TRxADE Health, Inc. (NASDAQ: MEDS) from 2014 to June 2024. Mr.Patel served as a director and president of Sceinture Holdings Inc. (NASDAQ: SCNX) from June 2023 to May 2025. Mr.Patel served as a director and president of Wellgistics Health, Inc. (f/k/a Danam Health Inc. (NASDAQ: WGRX)) from January 2024 to August 2025. Additionally, Mr. Patel has been a board advisor to several special purpose acquisition companies over the years prior to their initial business combination, including